[3] [4] Eligibility for weight loss medication in the UK depends on the specific medicine and is determined by NICE guidance and individual clinical assessment: Orlistat is generally considered for adults with a BMI of 30 kg/m or above, or a BMI of 28 kg/m or above in the presence of weight-related comorbidities such as type 2 diabetes or hypertension
Potential benefits of methylene blue include cognitive enhancement, support for mitochondria, antioxidant effects, microbial control, and its use as a stain in research
Previous weight loss attempts and why they succeeded or failed
50mg Vial Strong long-term value This is the size most people move to after trying the 30mg
However, in a head-to-head comparison with liraglutide, the latter demonstrated superior glycemic control and greater weight reduction after 26 weeks (HbA1c reduction of 1.5% vs 1.3% and weight loss of 3.6 kg vs 2.7 kg)
A: Every patient must start with the introductory 2.5mg dosage for the first 4 weeks to allow the body to build tolerance